According to Biotest 's latest financial reports the company's current EPS (TTM) is -HK$2.17. In 2022 the company made an earnings per share (EPS) of -HK$6.62 an increase over its 2021 EPS that were of -HK$14.48.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$2.20 | -66.71% |
2022 | -HK$6.62 | -54.27% |
2021 | -HK$14.48 | 99.36% |
2020 | -HK$7.26 | 471.15% |
2019 | -HK$1.27 | -103.03% |
2018 | HK$41.93 | -9663.05% |
2017 | -HK$0.44 | -95.43% |
2016 | -HK$9.60 | -47.94% |
2015 | -HK$18.44 | -468.28% |
2014 | HK$5.01 | -42.66% |
2013 | HK$8.73 | -8.51% |
2012 | HK$9.54 | -31.45% |
2011 | HK$13.92 | 30.12% |
2010 | HK$10.70 | 36.09% |
2009 | HK$7.86 |